Tab Title Description
Primary Objective
The primary objective of this registry is to obtain long-term
survivorship data for the use of fresh OCAs in cartilage repair and reconstruction procedures.
Secondary Objective
The secondary objective of this registry is to evaluate changes in physical function, pain, quality of life and patient satisfaction as
assessed by physician- and patient-reported outcomes.
REGISTRY ENDPOINTS
Primary Endpoints
Longitudinal survivorship measured by the incidence of graft failure
(i.e., graft revision or removal procedures).
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
1. Subject is over the age of 12 at the time of surgery
2. Has at least one cartilage defect present in the knee joint
3. Has a cartilaginous defect as determined by a medical professional
4. Is a candidate for surgical use of fresh osteochondral allografts for a primary or revision procedure
5. Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry
protocol
Exclusion Criteria
1. None
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic principal investigator
Aaron Krych, M.D.
Open for enrollment
Sejal Dave
5072669085
Contact Usdave.sejal@mayo.edu